CE

Cerecor

- NASDAQ:CERC
Last Updated 2021-09-14

LinkedIn Profile

Access Cerecor historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
nasdaq:cerc 3324084 Sep 2nd, 2021 12:00AM Avalo Therapeutics 1.3K 41.00 Open Biotechnology Sep 2nd, 2021 09:45AM Sep 2nd, 2021 09:45AM Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need. Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success. We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases. Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases. Open Open 540 Gaither Road , Suite 400 Rockville Maryland US 20850
nasdaq:cerc 3324084 Sep 1st, 2021 12:00AM Avalo Therapeutics 1.3K 41.00 Open Biotechnology Sep 1st, 2021 08:34AM Sep 1st, 2021 08:34AM Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need. Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success. We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases. Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases. Open Open 540 Gaither Road , Suite 400 Rockville Maryland US 20850
nasdaq:cerc 3324084 Aug 31st, 2021 12:00AM Avalo Therapeutics 1.3K 40.00 Open Biotechnology Aug 31st, 2021 08:30AM Aug 31st, 2021 08:30AM Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need. Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success. We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases. Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases. Open Open 540 Gaither Road , Suite 400 Rockville Maryland US 20850
nasdaq:cerc 3324084 Aug 30th, 2021 12:00AM Avalo Therapeutics 1.3K 41.00 Open Biotechnology Aug 30th, 2021 09:47AM Aug 30th, 2021 09:47AM Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need. Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success. We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases. Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases. Open Open 540 Gaither Road , Suite 400 Rockville Maryland US 20850
nasdaq:cerc 3324084 Aug 29th, 2021 12:00AM Avalo Therapeutics 1.3K 41.00 Open Biotechnology Aug 29th, 2021 03:43PM Aug 29th, 2021 03:43PM Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need. Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success. We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases. Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases. Open Open 540 Gaither Road , Suite 400 Rockville Maryland US 20850
nasdaq:cerc 3324084 Aug 28th, 2021 12:00AM Avalo Therapeutics 1.3K 43.00 Open Biotechnology Aug 28th, 2021 02:14PM Aug 28th, 2021 02:14PM Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need. Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success. We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases. Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases. Open Open 540 Gaither Road , Suite 400 Rockville Maryland US 20850
nasdaq:cerc 3324084 Aug 27th, 2021 12:00AM Avalo Therapeutics 1.3K 43.00 Open Biotechnology Aug 27th, 2021 10:00AM Aug 27th, 2021 10:00AM Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need. Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success. We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases. Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases. Open Open 540 Gaither Road , Suite 400 Rockville Maryland US 20850
nasdaq:cerc 3324084 Aug 26th, 2021 12:00AM Cerecor Inc. 1.2K 44.00 Open Biotechnology Aug 26th, 2021 08:37AM Aug 26th, 2021 08:37AM Cerecor is building a global biopharmaceutical enterprise with a near-term pipeline of 6 clinical assets and 8 ongoing clinical programs. All of our pipeline products have unique and novel mechanisms of action with the potential to be first-in-class compounds. Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases. Open Open 540 Gaither Road , Suite 400 Rockville Maryland US 20850
nasdaq:cerc 3324084 Aug 25th, 2021 12:00AM Cerecor Inc. 1.2K 44.00 Open Biotechnology Aug 25th, 2021 08:36AM Aug 25th, 2021 08:36AM Cerecor is building a global biopharmaceutical enterprise with a near-term pipeline of 6 clinical assets and 8 ongoing clinical programs. All of our pipeline products have unique and novel mechanisms of action with the potential to be first-in-class compounds. Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases. Open Open 540 Gaither Road , Suite 400 Rockville Maryland US 20850
nasdaq:cerc 3324084 Aug 24th, 2021 12:00AM Cerecor Inc. 1.2K 44.00 Open Biotechnology Aug 24th, 2021 07:59AM Aug 24th, 2021 07:59AM Cerecor is building a global biopharmaceutical enterprise with a near-term pipeline of 6 clinical assets and 8 ongoing clinical programs. All of our pipeline products have unique and novel mechanisms of action with the potential to be first-in-class compounds. Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases. Open Open 540 Gaither Road , Suite 400 Rockville Maryland US 20850

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.